Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest HeartWare International Inc. Stories

2013-07-19 08:26:32

FRAMINGHAM, Mass. and SYDNEY, July 19, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2013, at 8:00 a.m. U.S. Eastern Daylight Time on Thursday, August 8, 2013. The Company plans to release the financial results prior to the conference call. The conference call with management will discuss the Company's financial results, highlights from the second...

2013-06-17 08:29:28

- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass., and SYDNEY, June 17, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE...

2013-06-13 08:28:38

FRAMINGHAM, Mass. and SYDNEY, June 13, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 9:25 a.m. EDT on Tuesday, June 18, 2013. The conference is being held June 18-19 at...

2013-06-12 08:28:47

FRAMINGHAM, Mass. and SYDNEY, June 12, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR - ASX:HIN), today announced that it has requested and received approval from ASX Limited for its removal from the official list of ASX. Trading in HeartWare's CHESS Depositary Interests (CDIs) will be suspended on ASX at the close of market on September 10, 2013. HeartWare's shares of common stock are currently listed for trading on the NASDAQ Global Select Market (NASDAQ) under the...

2013-06-11 08:27:22

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, June 11, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Haemonetics Corp. (NYSE: HAE), Insulet Corporation (NASDAQ: PODD), DexCom, Inc. (NASDAQ: DXCM), Heartware International Inc. (NASDAQ: HTWR), and Mindray Medical International Limited (NYSE: MR). Today's readers may access these reports free of charge - including full price targets, industry...

2013-06-04 12:27:56

FRAMINGHAM, Mass. and SYDNEY, June 4, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Goldman Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 am EDT) on Wednesday, June 12, 2013. The conference is being held June 11-13 at...

2013-05-16 16:25:36

FRAMINGHAM, Mass. and SYDNEY, May 16, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, May 20, 2013. The conference is being held May 20-22, 2013 at the Sheraton New...

2013-05-10 16:23:53

FRAMINGHAM, Mass. and SYDNEY, May 10, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2013 Health Care Conference at 8:00 a.m. PDT (11:00 am EDT) on Thursday, May 16, 2013. The conference is being held May...

2013-04-29 16:30:55

- U.S. Revenues of $26.2 million, from $6.4 million in First Quarter of 2012; Reflecting First Complete Quarter of Commercialization in U.S. - FRAMINGHAM, Mass. and SYDNEY, April 29, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $49.2 million for the first quarter ended March...

2013-04-15 08:27:54

FRAMINGHAM, Mass. and SYDNEY, April 15, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended March 31, 2013, at 5:00 p.m. U.S. Eastern Daylight Time on Monday, April 29, 2013. The Company plans to release the financial results prior to the conference call. The conference call with management will discuss the Company's financial results, highlights from the first quarter and...